PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Continuous R&D Keeps European CoenzymeQ10 Market in Pink of Health - Ongoing discovery of CoenzymeQ10s health benefits enhances the overall market, especially for European marketers and manufacturers who already successfully capitalized on proven cardiac benefits of the enzyme
Continuous R&D Keeps European CoenzymeQ10 Market in Pink of Health

 

NewswireToday - /newswire/ - Palo Alto, CA, United States, 2008/06/09 - Ongoing discovery of CoenzymeQ10s health benefits enhances the overall market, especially for European marketers and manufacturers who already successfully capitalized on proven cardiac benefits of the enzyme.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Market participants now increasingly focus their development efforts on the newly discovered role that CoQ10 plays in cellular energy production, healthy vision, migraine relief and infertility treatment. This emphasis on new health profiles and applications will help industry players expand their customer base and product portfolio.

New analysis from Frost & Sullivan (food.frost.com) Europe CoenzymeQ10 Markets, finds the market earned revenues of $14.8 million in 2007 and estimates this to reach $35.1 million in 2014.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the Europe CoQ10 markets, send an email to Johanna Haynes, Corporate Communications, at jhaynes_pr[.]frost.com with the following information: your full name, company name, title, company telephone number, company email address, city, state, and country. We will send you the information via email upon receipt of the above information. All media inquiries please reply directly to johanna.haynes[.]frost.com.

Most consumers choose dietary supplements based on their health claims, along with the product's purpose and price. Of these, health claims are the most influential and challenging factor for the European CoQ10 manufacturers, since health claim regulations in Europe are much more stringent and demanding than in other regions. Consequently, European manufacturers will be hard-pressed to establish scientific credibility and overcome regulatory hurdles to develop successful health claims.

Many manufacturers operating in Europe find it daunting to perform multiple levels of testing and scientific research on certain ingredients before they are approved in Europe. The process is not only expensive, but can also be extremely lengthy.

Manufacturers must have a thorough understanding of regulatory procedures while developing novel applications or marketing new benefits of CoQ10 in Europe. While existing manufacturers may have the experience to cope with the regulatory requirements, new entrants must tread carefully with regard to health claims and product development.

New product development, however, is a key activity for market expansion. In the past, for example, manufacturers supplied the majority of CoQ10 in the form of a fat-soluble compound and end users complained about its suitability for beverages. Now, manufacturers and marketers are rapidly offering value-added versions of CoQ10, which are typically enclosed in a matrix or are in a beadlet form. These formulations offer greater stability and ease of formulation into beverages.

Formulators have also developed versions that contain nanograde materials, which could increase the surface area and therefore, the bio-availability of the product. These developments mean that CoQ10 could be increasingly used in functional beverages,, which is the fastest growing application sector within the functional food and beverage market.

Revenues expect to increase now that the supply of CoQ10 is stable and prices returned to pre-surge levels. The rising costs of healthcare and consumer interest in preventative healthcare will also lift CoQ10 sales. These trends, along with the discovery of new health benefits, creates a huge market for CoQ10 in supplements and functional foods

Europe CoenzymeQ10 Markets is part of the Food & Beverage Ingredients Growth Partnership Service program, which also includes research in the following markets: enzymes in food and feed applications, U.S. prebiotics markets, global lutein market and U.S. CoenzymeQ10 markets. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

Europe CoenzymeQ10 Markets
N29C

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Continuous R&D Keeps European CoenzymeQ10 Market in Pink of Health

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Johanna Haynes 
210.247.3870 johanna.haynes[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)